ArticleBiomimetics (Basel, Switzerland)2023
A Novel Artificial-Intelligence-Based Approach for Classification of Parkinson's Disease Using Complex and Large Vocal Features.
Article in Biomimetics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Bio-Inspired Deep Learning for Parkinson's Disease Detection: A Comparative Study Based on Vocal Biomarkers and Archimedean Spiral Analysis.Biomimetics (Basel, Switzerland) · 2026Article
- Applications of Artificial Intelligence in Neurological Voice Disorders.World journal of otorhinolaryngology - head and neck surgery · 2025Review
- Voice-Based Detection of Parkinson's Disease Using Machine and Deep Learning Approaches: A Systematic Review.Bioengineering (Basel, Switzerland) · 2025Review
- Voice-Based Early Diagnosis of Parkinson's Disease Using Spectrogram Features and AI Models.Bioengineering (Basel, Switzerland) · 2025Article
- Voice biomarkers as prognostic indicators for Parkinson's disease using machine learning techniques.Scientific reports · 2025Article
- Innovation through Artificial Intelligence in Triage Systems for Resource Optimization in Future Pandemics.Biomimetics (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Parkinson's disease (PD) affects a large proportion of elderly people. Symptoms include tremors, slow movement, rigid muscles, and trouble speaking. With the aging of the developed world's population, this number is expected to rise. The early detection of PD and avoiding its severe consequences require a precise and efficient system. Our goal is to create an accurate AI model that can identify PD using human voices. We developed a transformer-based method for detecting PD by retrieving dysphonia measures from a subject's voice recording. It is uncommon to use a neural network (NN)-based solution for tabular vocal characteristics, but it has several advantages over a tree-based approach, including compatibility with continuous learning and the network's potential to be linked with an image/voice encoder for a more accurate multi modal solution, shifting SOTA approach from tree-based to a neural network (NN) is crucial for advancing research in multimodal solutions. Our method outperforms the state of the art (SOTA), namely Gradient-Boosted Decision Trees (GBDTs), by at least 1% AUC, and the precision and recall scores are also improved. We additionally offered an XgBoost-based feature-selection method and a fully connected NN layer technique for including continuous dysphonia measures, in addition to the solution network. We also discussed numerous important discoveries relating to our suggested solution and deep learning (DL) and its application to dysphonia measures, such as how a transformer-based network is more resilient to increased depth compared to a simple MLP network. The performance of the proposed approach and conventional machine learning techniques such as MLP, SVM, and Random Forest (RF) have also been compared. A detailed performance comparison matrix has been added to this article, along with the proposed solution's space and time complexity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.